Cancer’s Week in the Spotlight
15 January 2016 In News, Science
Cancer has been in the news a lot this week. We learned that two pop-culture artists – David Bowie and Alan Rickman – lost their battles with cancer. It’s a stark contrast to the news we heard last month about President Jimmy Carter, who has had a positive treatment response...
Researcher Q&A: Dr. John D’Orazio
7 January 2016 In Science
In the latest blog post, we chatted with the University of Kentucky’s John D’Orazio, M.D., Ph.D., a pediatric hematologist oncologist, and a 2015 MRA grant awardee. Read on to learn what he has to say about melanoma research and prevention efforts.
Fast and Furious: Melanoma Research in 2015
By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 28 December 2015 In Science, Treatment
The world of melanoma has changed dramatically in a way one might not have envisioned in 2011. How can you tell? From the stories of patients and their caregivers. A common story can go like this: Just diagnosed with Stage 4 melanoma.
Daughter Celebrates Her Mom's Health This Holiday Season
By Hilary Rogers | 21 December 2015 In Melanoma Stories
In this guest post, Hilary Rogers, a member of the Leveraged Finance Fights Melanoma Steering Committee, shares her perspective on her mom's battle with melanoma. In the winter of 2012, my family and I found out that our mother’s stage 3 melanoma diagnosis had progressed to her lungs.
Is a Clinical Trial Right for You?
11 December 2015 In Science, Treatment
Before the U.S. Food and Drug Administration (FDA) approves a medication or treatment for public use, it first must go through several phases of study which is known as a clinical trial. During each phase, researchers evaluate how well the treatment works and take note of any side effects.
Researcher Q&A: Dr. Vashisht Yennu Nanda
3 December 2015 In Science
MD Anderson\'s Dr. Yennu Nando explains his research for melanoma.
Giving Thanks
By Logan Kastner, MRA Director of Marketing and Development | 24 November 2015 In Allies & Partnerships
DONATE
Research Q & A: Dr. Michael Atkins
17 November 2015 In Treatment
In the latest blog series, we talked with Dr. Michael Atkins, Deputy Director of the Georgetown-Lombardi Cancer Center at Georgetown University, and a member of the MRA Medical Advisory Panel.
Partnering for Cures: How Patients Can Stop Talking and Start Doing Something
6 November 2015 In Events, Melanoma Stories
Earlier this week, more than 700 thought leaders from throughout the healthcare industry gathered in New York for FasterCures’ Partnering for Cures meeting. This annual event brings together a variety of decision-makers from across diseases who are motivated by the same mission – to reduce the time and cost of...
Immunotherapy Patient Forum: 6 Reasons to Attend
27 October 2015 In Events
On November 7, the Melanoma Research Alliance is co-hosting a Patient Forum on Immunology with Global Resource for Advancing Cancer Education and the Society for Immunotherapy of Cancer. The event will be held at the National Harbor, near Washington, DC. Online registration is open through October 30.
Tag Cloud
Adjuvant Therapy Advocacy ASCO Awareness Biopharma Board Members BRAF Cancer Combination Therapy Detection FDA Francis Collins Grants Health HHS Immunotherapy Louise Perkins Melanoma microbiome MRA News Nonprofits Partners Patient Forum Patient Stories Patient-Centric Care Patients Pediatric Melanoma Prevention Redheads Research Science Social Media Surgeon General Surgeon General's Call to Action to Prevent Skin Cancer Targeted Therapy Teens Treatment Wendy Selig Young Investigators Young People